The national daytime talk show The Doctors presented the landmark surgical procedure involving the use of UF startup AxoGen’s AxoGuard® Nerve Protector. The segment featured an interview with Dr. Ajay K. Seth, an orthopedic surgeon at Spectrum Orthopedics in Canton, Ohio, and his patient, 44-year-old Melissa Loomis, whose arm was amputated above the elbow following a raccoon bite that became infected.
Seth reduced Loomis’ nerve pain and restored some nerve function to her arm by using Axogen’s AxoGuard® Nerve Protector to isolate and protect nerves, serving as a soft tissue graft. Melissa now has motor control as well as simulated sensory feedback allowing her to feel each of the five fingers on her prosthesis. The surgery was also successful in alleviating Melissa’s pain.
UF startup Altavian Inc. is using its unmanned aerial systems in partnership with a Dayton, Ohio, community college to collect data for NASA engineers. Sinclair Community College and Altavian announced that the school would use the company’s fixed-wing Nova F7200 and its Galaxy R8700 octocopter, carrying a NASA sensor, to better understand the algae blooms that have plagued parts of Lake Erie for years.
Funded by the state of Ohio and the University of Toledo, some 30 NASA engineers and staff are working with the college and Altavian, in what members are calling “a cross-functional team.”
UF startup ViewRay, Inc. announced that the company has received CE Mark approval for its next generation linear accelerator-based MRI-guided radiation therapy system, the MRIdian Linac. The MRIdian Linac builds on the first generation MRIdian system, but replaces cobalt with linear accelerator technology.
The MRIdian is the world’s first and only clinical MRI-guided radiation therapy system.
In addition to receiving CE Mark approval for the MRIdian Linac in Europe, the company has also submitted its 510(k) application for the MRIdian Linac technology in the United States.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded UF startup Nanotherapeutics, Inc. a contract for advanced biologics manufacturing services. The startup is a contract development and manufacturing organization, and the contract is part of a multiple award IDIQ (Indefinite Delivery/Indefinite Quantity) pool. It has a maximum ceiling of $159.4 million and a performance period of up to 10 years.
“Our contract with the NIAID represents a major achievement for the company,” stated Robert V. House, Ph.D., Nanotherapeutics’ Senior Vice President, Government Contracts. “Having successfully fulfilled numerous contracts for various divisions of the U.S. Government over the past 16 years, this new award is a reflection of the strength of Nanotherapeutics’ advanced biologics expertise and proven development and manufacturing capabilities.”
BTIG Equity Research initiated Viewray Inc. shares with a Buy rating and a 12-month price objective of $6 based on the expectations of hospital arms race in live imaging. The comments come on the heels of the UF startup company receiving Chinese regulatory approval for its MRIdian system, as China is considered as one of the biggest markets for medical devices.
BTIG analysts, led by Sean Lavin, believe ViewRay is the only company providing a radiation option that images while treating. The lead analyst thinks that MRIdian system could provide better outcomes with fewer side effects.
UF startup AxoGen, Inc., a global leader in innovative surgical solutions for peripheral nerve injuries, will participate in the 71stAnnual American Society for Surgery of the Hand Meeting taking place in Austin, Texas, from September 29 – October 1.
AxoGen will sponsor several special programs that support peripheral nerve education and awareness, including the Hand Fellows pre-course program, the “Women in Hand Surgery” event and a surgeon-led symposium — “Tackling Challenges in Nerve Repair: A Case-Based Discussion.”
Sappi North America has entered into an exclusive, worldwide license agreement with UF startup Sharklet Technologies, Inc. to manufacture and distribute casting and release paper featuring the ground-breaking Sharklet™ microtexture.
The new release paper is the first of its kind which creates surfaces that inhibit bacterial growth without the use of toxic additives or chemicals. Sappi has developed new technology to impart the Sharklet microtexture, at micron-level fidelity, onto its release papers, and manufacturers can now transfer the Sharklet micropattern and its microbial resistance properties onto new product surfaces. The product will be the first in Sappi’s new Neoterix™ line and will be available to customers under the name Neoterix ST.
Therapist Assisted Online, a treatment by UF startup TAO Connect, uses cognitive behavioral therapy modules that include videos and informational presentations. The modules teach clients about what causes depression and anxiety; how to identify common symptoms and personal triggers; and what strategies and techniques people can use to overcome their problems. For example, to treat anxiety, students learn deep breathing, mindfulness meditation and visualization.
The online program assists clients going through treatment for mild to moderate anxiety. Research results show that TAO Connect works as well as traditional therapy and is a great fit for highly motivated students who want to get better quicker.
The Boca Raton-based angel-investor group New World Angels has again plunked down hundreds of thousands into UF startup OBMedical.
NWA closed a $538,000 investment into the company, which develops wireless fetal monitors called LaborView. Previously, the angel group invested on two occasions — $1.1 million and $527,500 — in OBMedical.
“New World Angels is delighted to continue to support the growth of OBMedical and the expansion of a product that improves the labor and delivery process for women,” said NWA president Steve O’Hara.
The Henry Ford Health System will acquire UF startup ViewRay’s linear accelerator technology and plans to conduct studies using this linear accelerator-based radiotherapy technology.
Nearly two-thirds of all treated cancer patients in the United States will receive some form of radiation therapy during the course of their illness, according to estimates by the American Society for Radiation Oncology. Precision delivery of radiation therapy is a challenge because tumors and internal organs continually move during treatment. ViewRay’s MRI-guided technology improves the ability to aim radiation therapy directly at tumors, while avoiding surrounding tissues.